Revolution Medicines RVMD Insider Ownership

NASDAQ RVMD

$177.96 -11.30 (-5.97%)

At close: Oct 16, 2026 · 4:00 PM EDT

Insider Holdings by Owner

11.77Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

5.85%

▼-0.028% pp QoQ

Shares Held by Insiders

12.53Mn

filed for Sep 2026

▼-0.48% QoQ

Shares Outstanding

214.24Mn

214,242,688 shares

Direct Holdings

3.69Mn

Indirect: 8.84Mn

Net Shares Traded (QoQ)

-60.14K

net selling in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 11, 2026

Across the past 12 months, open-market trades by Revolution Medicines insiders were all sales, totaling $156.71 million (1.1Mn shares).

Counted by insider, open-market selling of RVMD stock in the past 12 months came from 12 insiders, with no insider buying.
The largest open-market sales of RVMD in the past 12 months were by Mark A. Goldsmith (Director and officer), totaling $56.99 million (450.27K shares), most recently on September 16, 2026.
The latest open-market trade on record is a sale of 6.31K shares for $1.28 million by Alan B. Sandler (Chief Development Officer) on September 29, 2026.
Beyond open-market trades, insiders at Revolution Medicines received 129.19K shares in stock awards, acquired 893.83K shares through option exercises and conversions and gave away 115K shares as gifts in the last 12 months.
Business Quant data shows Revolution Medicines insiders holding 12.52Mn shares in total in their latest Form 4 filings, or 5.84% of the 214.24Mn shares outstanding; that total is down 0.58% from 12.59Mn shares at the end of Q2 2026 and up 0.49% from 12.46Mn shares at the end of Q3 2025.
Direct holdings account for 3.67Mn shares (29.34%) of RVMD's insider total, and indirect holdings through trusts, partnerships and family members for 8.84Mn shares (70.66%).
Holdings in Revolution Medicines stock are reported by 17 insiders, the officers, directors and 10% owners who have filed a Form 4 in the past two years.
Revolution Medicines' top three insider holders by shares held are Thilo Schroeder (Director, 8.09Mn shares), Alexis Borisy (Director, 2.34Mn shares) and Mark A. Goldsmith (Director and officer, 970.25K shares).
Thilo Schroeder holds 64.60% of the combined insider position in Revolution Medicines.
A total of 72 Form 4 filings with transactions in Revolution Medicines stock were made over the past 12 months, by 16 insiders.
This summary of Revolution Medicines insider activity covers Form 4 filings through October 1, 2026.

Form 4 Holdings

Insiders Holding RVMD

Insiders 21

Shares held 11.77Mn

Of outstanding 5.49%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Rock Ventures Iii, L.P. Third	TenPercentOwner	5,104,130	0	5,104,130	43.4%	10 Jun, 2022
2	Thilo Schroeder	Director	0	2,857,481	2,857,481	24.3%	09 Dec, 2024
3	Alexis Borisy	Director	2,340,075	0	2,340,075	19.9%	23 Jun, 2026
4	Stephen Michael Kelsey	Officer	286,307	0	286,307	2.4%	18 Sep, 2026
5	Mark A Goldsmith	Director, Officer	253,342	0	253,342	2.2%	18 Sep, 2026
6	Margaret A Horn	Chief Operating Officer	149,680	0	149,680	1.3%	18 Sep, 2026
7	Jack Anders	Chief Financial Officer	119,216	0	119,216	1.0%	18 Sep, 2026
8	Xiaolin Wang	Officer	116,063	0	116,063	1.0%	19 Mar, 2026
9	Lin Wei	Chief Medical Officer	101,366	0	101,366	0.9%	19 Mar, 2026
10	Sandra Horning	Director	97,765	0	97,765	0.8%	23 Jun, 2026
11	Lorence H. Kim	Director	74,281	0	74,281	0.6%	23 Jun, 2026
12	Alan B. Sandler	Chief Development Officer	52,559	0	52,559	0.4%	01 Oct, 2026
13	Jeff Cislini	Svp General Counsel	51,776	0	51,776	0.4%	29 Sep, 2026
14	Anthony Mancini	Officer	39,765	0	39,765	0.3%	28 Sep, 2026
15	Neil Exter	Director	28,815	0	28,815	0.2%	17 Jun, 2022
16	Flavia Borellini	Director	26,215	0	26,215	0.2%	23 Jun, 2026
17	Sushil Patel	Director	21,656	0	21,656	0.2%	01 Jul, 2026
18	Eric Thomas Schmidt	Director	21,251	0	21,251	0.2%	12 Jun, 2023
19	Barbara Weber	Director	13,065	0	13,065	0.1%	10 Oct, 2024
20	Frank Clyburn	Director	10,929	0	10,929	0.1%	23 Jun, 2026
21	Elizabeth M Anderson	Director	4,333	0	4,333	0.0%	24 Sep, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

1,026 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
29 Sep, 2026	Alan B. Sandler	Chief Development Officer	Acquired M	6,000	$58.84	$353.04K	58,868	Direct
29 Sep, 2026	Alan B. Sandler	Chief Development Officer	Disposed S	2,200	$200.82	$441.80K	56,668	Direct
29 Sep, 2026	Alan B. Sandler	Chief Development Officer	Disposed S	1,609	$201.72	$324.57K	55,059	Direct
29 Sep, 2026	Alan B. Sandler	Chief Development Officer	Disposed S	1,000	$202.81	$202.81K	54,059	Direct
29 Sep, 2026	Alan B. Sandler	Chief Development Officer	Disposed S	1,199	$203.91	$244.48K	52,860	Direct
29 Sep, 2026	Alan B. Sandler	Chief Development Officer	Disposed S	301	$204.72	$61.62K	52,559	Direct
29 Sep, 2026	Alan B. Sandler	Chief Development Officer	Disposed M	6,000	$0.00	$0	161,300	Direct
25 Sep, 2026	Jeff Cislini	Svp General Counsel	Disposed S	765	$207.32	$158.60K	51,776	Direct
24 Sep, 2026	Anthony Mancini	Officer	Disposed S	587	$200.00	$117.40K	39,765	Direct
25 Sep, 2026	Anthony Mancini	Officer	Acquired M	3,121	$33.62	$104.93K	42,886	Direct
25 Sep, 2026	Anthony Mancini	Officer	Disposed S	3,121	$200.54	$625.89K	39,765	Direct
25 Sep, 2026	Anthony Mancini	Officer	Disposed M	3,121	$0.00	$0	93,625	Direct
22 Sep, 2026	Elizabeth M Anderson	Director	Acquired M	5,070	$1.12	$5.68K	14,476	Direct
22 Sep, 2026	Elizabeth M Anderson	Director	Disposed S	910	$191.85	$174.59K	13,566	Direct
22 Sep, 2026	Elizabeth M Anderson	Director	Disposed S	4,985	$192.54	$959.81K	8,581	Direct
22 Sep, 2026	Elizabeth M Anderson	Director	Disposed S	2,648	$193.44	$512.23K	5,933	Direct
22 Sep, 2026	Elizabeth M Anderson	Director	Disposed S	1,500	$194.59	$291.88K	4,433	Direct
22 Sep, 2026	Elizabeth M Anderson	Director	Disposed S	100	$195.15	$19.52K	4,333	Direct
22 Sep, 2026	Elizabeth M Anderson	Director	Disposed M	5,070	$0.00	$0	1,095	Direct
18 Sep, 2026	Anthony Mancini	Officer	Disposed S	1,764	$196.94	$347.40K	40,352	Direct

Showing 1 to 20 of 1,026 transactions